ClinicalTrialsFinder
RecruitingNot ApplicableNCT05420233

The CROCO Study: CROhn's Disease COhort Study

Sponsor

GLSMED Learning Health S.A.

Enrollment

600 participants

Start Date

Aug 1, 2021

Study Type

INTERVENTIONAL

Conditions

Crohn Disease

Summary

The investigators propose to create a prospective Crohn Disease cohort, where patients receiving the most up-to-date therapies with a treat-to-target strategy, will be closely followed to characterize the progression of Crohn Disease by measuring the Lémann Index over time. The goal of the CROCO Study - "Crohn's Disease Cohort Study" is to promote a greater understanding of the long-term evolution of Crohn Disease , to describe prospectively the impact of different therapeutic strategies and develop accurate predictors of bowel disease damage and disability.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an observational study following people newly diagnosed with Crohn's disease (an inflammatory bowel disease that causes chronic inflammation of the digestive tract). Researchers will track patients over time to better understand how the disease progresses and how different treatments work in real-world practice. **You may be eligible if...** - You have been diagnosed with Crohn's disease within the past 12 months - You are 18 or older - You are able to understand the study information and provide written consent **You may NOT be eligible if...** - Your Crohn's diagnosis was made more than 12 months ago - You have been diagnosed with ulcerative colitis instead of Crohn's - You are unable to give informed consent - You are currently enrolled in a clinical trial that could interfere with this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMRE

Magnetic Resonance Enterography at year 1 (in some patients)

Locations(20)

University Hospital CHU of Liège

Liège, Liège, Belgium

American Gastroenterology Center

Stróvolos, Cyprus

IBD Clinical and Research Clinic, ISCARE

Prague, Czechia

Hvidovre Hospital

Hvidovre, Denmark

Slagelse Hospital

Slagelse, Denmark

CHU Amiens-Picardie Hôpital Sud

Amiens, France

CHU Estaing Clermont - Ferrand

Clermont-Ferrand, France

Claude Huriez Hospital, Lille University

Lille, France

Azienda Ospedaliera di Padova

Padova, Italy

Ospedale San Raffaele

San Raffaele, Italy

Mater dei hospital

Msida, Malta

Hospital Garcia da Orta

Almada, Almada, Portugal

Instituto Portugues de Oncologia de Lisboa

Lisbon, Lisbon District, Portugal

Hospital Beatriz Angelo

Loures, Loures, Portugal

Algomed Policlinic

Timișoara, Romania

Hospital Clinic Barcelona

Barcelona, Spain

Hospital Galdakao-Usansolo

Galdakao, Spain

Hospital Alvaro Cunqueiro - Área Sanitária de Vigo

Vigo, Spain

Hull University Teaching Hospitals NHS Trust

Hull, United Kingdom

St Mark's Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05420233

Related Trials

Standardized Microbiota Transplant Therapy in Crohn's Disease

NCT066315862 locations

A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease

NCT062212544 locations

Predictors of Prognosis in IBD Patients

NCT056530111 location

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

NCT060946081 location

Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group

NCT0345819517 locations